Temporal	O
Gene	O
Expression	O
Kinetics	O
for	O
Human	B-OG
Keratinocytes	O
Exposed	O
to	O
Hyperthermic	O
Stress	O

The	O
gene	O
expression	O
kinetics	O
for	O
human	B-OG
cells	O
exposed	O
to	O
hyperthermic	O
stress	O
are	O
not	O
well	O
characterized	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
and	O
characterized	O
the	O
genes	O
that	O
are	O
differentially	O
expressed	O
in	O
human	B-OG
epidermal	O
keratinocyte	O
(	O
HEK	O
)	O
cells	O
exposed	O
to	O
hyperthermic	O
stress	O
.	O

In	O
order	O
to	O
obtain	O
temporal	O
gene	O
expression	O
kinetics	O
,	O
we	O
exposed	O
HEK	O
cells	O
to	O
a	O
heat	O
stress	O
protocol	O
(	O
44	O
°	O
C	O
for	O
40	O
min	O
)	O
and	O
used	O
messenger	O
RNA	O
(	O
mRNA	O
)	O
microarrays	O
at	O
0	O
h	O
,	O
4	O
h	O
and	O
24	O
h	O
post	O
-	O
exposure	O
.	O

Bioinformatics	O
software	O
was	O
employed	O
to	O
characterize	O
the	O
chief	O
biological	O
processes	O
and	O
canonical	O
pathways	O
associated	O
with	O
these	O
heat	O
stress	O
genes	O
.	O

The	O
data	O
shows	O
that	O
the	O
genes	O
encoding	O
for	O
heat	B-GP
shock	I-GP
proteins	I-GP
(	O
HSPs	B-GP
)	O
that	O
function	O
to	O
prevent	O
further	O
protein	O
denaturation	O
and	O
aggregation	O
,	O
such	O
as	O
HSP40	B-GP
,	O
HSP70	B-GP
and	O
HSP105	B-GP
,	O
exhibit	O
maximal	O
expression	O
immediately	O
after	O
exposure	O
to	O
hyperthermic	O
stress	O
.	O

In	O
contrast	O
,	O
the	O
smaller	O
HSPs	B-GP
,	O
such	O
as	O
HSP10	B-GP
and	O
HSP27	B-GP
,	O
which	O
function	O
in	O
mitochondrial	O
protein	O
biogenesis	O
and	O
cellular	O
adaptation	O
,	O
exhibit	O
maximal	O
expression	O
during	O
the	O
“	O
recovery	O
phase	O
”,	O
roughly	O
24	O
h	O
post	O
-	O
exposure	O
.	O

These	O
data	O
suggest	O
that	O
the	O
temporal	O
expression	O
kinetics	O
for	O
each	O
particular	O
HSP	B-GP
appears	O
to	O
correlate	O
with	O
the	O
cellular	O
function	O
that	O
is	O
required	O
at	O
each	O
time	O
point	O
.	O

In	O
summary	O
,	O
these	O
data	O
provide	O
additional	O
insight	O
regarding	O
the	O
expression	O
kinetics	O
of	O
genes	O
that	O
are	O
triggered	O
in	O
HEK	O
cells	O
exposed	O
to	O
hyperthermic	O
stress	O
.	O

1	O
.	O

Introduction	O

Human	B-OG
beings	O
frequently	O
encounter	O
a	O
wide	O
variety	O
of	O
hyperthermic	O
stressors	O
.	O

Common	O
examples	O
include	O
exposure	O
to	O
hot	O
conducting	O
objects	O
,	O
elevated	O
environmental	O
temperatures	O
,	O
as	O
well	O
as	O
electromagnetic	O
radiation	O
from	O
the	O
sun	O
and	O
numerous	O
man	B-OG
-	O
made	O
sources	O
,	O
such	O
as	O
lasers	O
,	O
communication	O
devices	O
and	O
imaging	O
systems	O
[	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
,	O
8	O
,	O
9	O
,	O
10	O
].	O

The	O
heat	O
generated	O
by	O
hyperthermic	O
stressors	O
can	O
be	O
harmful	O
to	O
organisms	O
,	O
because	O
it	O
can	O
temporarily	O
or	O
permanently	O
alter	O
the	O
conformation	O
and	O
function	O
of	O
vital	O
intracellular	O
biomacromolecules	O
(	O
i	O
.	O
e	O
.,	O
lipids	O
,	O
proteins	O
and	O
nucleic	O
acids	O
).	O

Such	O
modifications	O
can	O
result	O
in	O
an	O
array	O
of	O
damaging	O
effects	O
,	O
including	O
cellular	O
morphological	O
alterations	O
(	O
i	O
.	O
e	O
.,	O
shape	O
,	O
size	O
,	O
irregularities	O
and	O
roughness	O
),	O
cytoskeleton	O
restructuring	O
,	O
organelle	O
reorganization	O
and	O
/	O
or	O
fragmentation	O
and	O
direct	O
interference	O
with	O
intracellular	O
transport	O
processes	O
[	O
11	O
].	O

Hyperthermic	O
effects	O
can	O
interfere	O
with	O
an	O
organism	O
’	O
s	O
normal	O
homeostasis	O
,	O
and	O
thus	O
,	O
if	O
they	O
are	O
not	O
adequately	O
counteracted	O
,	O
they	O
can	O
threaten	O
its	O
survival	O
.	O

In	O
order	O
to	O
survive	O
and	O
minimize	O
the	O
effects	O
of	O
hyperthermic	O
stress	O
,	O
virtually	O
all	O
cells	O
in	O
living	O
organisms	O
have	O
evolved	O
sophisticated	O
sensing	O
,	O
response	O
and	O
adaptation	O
mechanisms	O
.	O

The	O
crux	O
of	O
these	O
mechanisms	O
is	O
the	O
molecular	O
defense	O
reaction	O
,	O
most	O
commonly	O
referred	O
to	O
as	O
the	O
cellular	O
stress	O
response	O
(	O
CSR	O
).	O

The	O
CSR	O
is	O
immediately	O
activated	O
in	O
response	O
to	O
stress	O
stimuli	O
,	O
and	O
a	O
hallmark	O
of	O
this	O
response	O
is	O
the	O
robust	O
transcriptional	O
expression	O
of	O
hundreds	O
of	O
diverse	O
genes	O
.	O

These	O
genes	O
encode	O
for	O
a	O
multitude	O
of	O
proteins	O
involved	O
in	O
many	O
important	O
functions	O
,	O
including	O
cellular	O
survival	O
,	O
deoxyribonucleic	O
acid	O
(	O
DNA	O
)	O
sensing	O
and	O
repair	O
,	O
redox	O
regulation	O
,	O
proteolysis	O
,	O
molecular	O
chaperoning	O
,	O
cell	O
cycle	O
control	O
and	O
apoptosis	O
[	O
12	O
,	O
13	O
].	O

Furthermore	O
,	O
each	O
CSR	O
gene	O
exhibits	O
unique	O
expression	O
profiles	O
,	O
which	O
differ	O
in	O
magnitude	O
,	O
onset	O
time	O
and	O
duration	O
of	O
expression	O
[	O
4	O
,	O
10	O
].	O

The	O
epidermis	O
,	O
the	O
outermost	O
layer	O
of	O
an	O
organism	O
’	O
s	O
skin	O
,	O
regularly	O
encounters	O
a	O
wide	O
variety	O
of	O
stressors	O
.	O

In	O
fact	O
,	O
the	O
primary	O
function	O
of	O
the	O
epidermis	O
is	O
to	O
give	O
organisms	O
a	O
physiological	O
protection	O
barrier	O
against	O
environmental	O
stimuli	O
,	O
such	O
as	O
hyperthermic	O
stressors	O
.	O

This	O
protective	O
role	O
is	O
mediated	O
primarily	O
by	O
keratinocytes	O
,	O
the	O
predominant	O
epithelial	O
cell	O
type	O
(~	O
95	O
%).	O

Due	O
to	O
their	O
anatomical	O
location	O
,	O
keratinocytes	O
are	O
habitually	O
exposed	O
to	O
environmental	O
temperature	O
variations	O
,	O
and	O
thus	O
,	O
they	O
are	O
the	O
primary	O
and	O
frequent	O
target	O
of	O
hyperthermic	O
stress	O
.	O

In	O
addition	O
,	O
their	O
frequent	O
exposure	O
to	O
heat	O
stress	O
has	O
also	O
been	O
reported	O
to	O
render	O
them	O
with	O
specialized	O
cellular	O
responses	O
,	O
which	O
make	O
them	O
more	O
resistant	O
to	O
stress	O
than	O
virtually	O
all	O
other	O
cell	O
types	O
[	O
14	O
,	O
15	O
].	O

Clearly	O
,	O
keratinocytes	O
carry	O
a	O
disproportionate	O
burden	O
in	O
maintaining	O
homeostasis	O
for	O
organisms	O
;	O
thus	O
,	O
they	O
are	O
vital	O
players	O
in	O
sensing	O
,	O
responding	O
and	O
adapting	O
to	O
the	O
burdens	O
of	O
hyperthermic	O
stress	O
.	O

Over	O
the	O
past	O
decade	O
,	O
numerous	O
microarray	O
experiments	O
have	O
been	O
performed	O
to	O
better	O
understand	O
the	O
stress	O
response	O
of	O
human	B-OG
epidermal	O
keratinocytes	O
(	O
HEK	O
)	O
[	O
15	O
,	O
16	O
,	O
17	O
,	O
18	O
,	O
19	O
].	O

These	O
studies	O
have	O
been	O
particularly	O
fruitful	O
,	O
because	O
they	O
have	O
resulted	O
in	O
the	O
identification	O
of	O
hundreds	O
of	O
stress	B-GP
-	I-GP
inducible	I-GP
genes	I-GP
.	O

However	O
,	O
previous	O
gene	O
expression	O
studies	O
have	O
failed	O
to	O
provide	O
a	O
comprehensive	O
picture	O
of	O
the	O
cellular	O
stress	O
response	O
for	O
several	O
reasons	O
.	O

First	O
,	O
the	O
microarray	O
gene	O
chips	O
utilized	O
in	O
most	O
of	O
the	O
previous	O
studies	O
were	O
incomplete	O
and	O
,	O
thus	O
,	O
provided	O
expression	O
kinetics	O
for	O
only	O
a	O
fraction	O
of	O
the	O
genes	O
in	O
the	O
human	B-OG
genome	O
.	O

Second	O
,	O
many	O
previous	O
studies	O
made	O
gene	O
expression	O
measurements	O
at	O
a	O
single	O
time	O
point	O
;	O
as	O
a	O
result	O
,	O
temporal	O
gene	O
expression	O
kinetics	O
could	O
not	O
be	O
ascertained	O
.	O

Finally	O
,	O
the	O
majority	O
of	O
past	O
studies	O
examined	O
the	O
response	O
of	O
skin	O
cells	O
to	O
ultraviolet	O
stress	O
;	O
however	O
,	O
few	O
studies	O
have	O
specifically	O
analyzed	O
the	O
transcriptional	O
response	O
of	O
HEK	O
to	O
hyperthermic	O
stress	O
[	O
10	O
].	O

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
identify	O
and	O
characterize	O
the	O
genes	O
that	O
are	O
differentially	O
expressed	O
in	O
HEK	O
exposed	O
to	O
hyperthermic	O
stress	O
.	O

To	O
obtain	O
temporal	O
gene	O
expression	O
kinetics	O
,	O
we	O
exposed	O
HEK	O
to	O
a	O
heat	O
stress	O
protocol	O
(	O
44	O
°	O
C	O
for	O
40	O
min	O
)	O
and	O
used	O
mRNA	O
microarrays	O
at	O
three	O
time	O
points	O
:	O
0	O
h	O
,	O
4	O
h	O
and	O
24	O
h	O
post	O
-	O
heat	O
treatment	O
,	O
as	O
outlined	O
in	O
Figure	O
1A	O
.	O

Then	O
,	O
we	O
used	O
bioinformatics	O
software	O
to	O
characterize	O
the	O
chief	O
biological	O
processes	O
and	O
canonical	O
pathways	O
associated	O
with	O
these	O
genes	O
.	O

These	O
data	O
provide	O
valuable	O
new	O
insights	O
that	O
give	O
us	O
a	O
much	O
clearer	O
picture	O
of	O
the	O
genes	O
and	O
intracellular	O
signaling	O
pathways	O
that	O
are	O
triggered	O
in	O
human	B-OG
cells	O
exposed	O
to	O
hyperthermic	O
stress	O
.	O

(	O
A	O
)	O
A	O
schematic	O
of	O
the	O
heat	O
shock	O
exposure	O
protocol	O
and	O
post	O
analysis	O
techniques	O
.	O

(	O
B	O
)	O
Cellular	O
MTT	O
viability	O
for	O
keratinocytes	O
exposed	O
to	O
hyperthermic	O
stress	O
.	O

Viability	O
percentage	O
data	O
(	O
relative	O
to	O
untreated	O
samples	O
)	O
was	O
measured	O
for	O
wells	O
with	O
concentration	O
densities	O
ranging	O
from	O
10	O
,	O
000	O
to	O
100	O
,	O
000	O
cells	O
per	O
well	O
.	O

Viability	O
was	O
measured	O
at	O
0	O
,	O
4	O
and	O
24	O
h	O
post	O
-	O
heat	O
treatment	O
.	O

(	O
C	O
)	O
Microarray	O
global	O
gene	O
expression	O
profiles	O
.	O

The	O
data	O
shows	O
that	O
762	O
,	O
1	O
,	O
422	O
and	O
1	O
,	O
478	O
total	O
genes	O
were	O
differentially	O
expressed	O
at	O
0	O
,	O
4	O
and	O
24	O
h	O
post	O
-	O
exposure	O
,	O
respectively	O
.	O

(	O
D	O
)	O
Gene	O
expression	O
for	O
minimal	O
stress	O
protein	O
,	O
heat	B-GP
shock	I-GP
protein	I-GP
70	I-GP
(	O
HSPA6	B-GP
)	O
using	O
qRT	O
-	O
PCR	O
.	O

The	O
mRNA	O
expression	O
fold	O
values	O
were	O
measured	O
for	O
sham	O
and	O
heat	O
treatment	O
groups	O
.	O

For	O
each	O
time	O
point	O
,	O
three	O
samples	O
(	O
S1	O
,	O
S2	O
and	O
S3	O
)	O
were	O
assessed	O
,	O
each	O
in	O
triplicates	O
.	O

Values	O
were	O
calculated	O
in	O
relation	O
to	O
β	B-GP
-	I-GP
actin	I-GP
and	O
normalized	O
to	O
a	O
separate	O
RNA	O
calibrator	O
.	O

2	O
.	O

Results	O
and	O
Discussion	O

2	O
.	O
1	O
.	O

Keratinocytes	O
Induce	O
an	O
Appreciable	O
Stress	O
Response	O
When	O
Exposed	O
To	O
Hyperthermic	O
Stress	O

We	O
conducted	O
an	O
initial	O
set	O
of	O
experiments	O
to	O
investigate	O
the	O
impact	O
that	O
our	O
selected	O
hyperthermia	O
stress	O
protocol	O
had	O
on	O
cellular	O
viability	O
.	O

For	O
these	O
studies	O
,	O
HEKs	O
were	O
exposed	O
to	O
hyperthermic	O
stress	O
and	O
cellular	O
metabolic	O
activity	O
was	O
measured	O
at	O
0	O
,	O
4	O
and	O
24	O
h	O
post	O
-	O
exposure	O
using	O
MTT	O
assays	O
(	O
Figure	O
1B	O
).	O

For	O
all	O
cell	O
densities	O
tested	O
,	O
the	O
data	O
shows	O
that	O
greater	O
than	O
90	O
%	O
of	O
the	O
cells	O
survive	O
after	O
being	O
exposed	O
to	O
our	O
hyperthermic	O
stress	O
protocol	O
.	O

This	O
data	O
confirms	O
that	O
the	O
HEKs	O
cells	O
were	O
viable	O
post	O
-	O
heat	O
exposure	O
.	O

After	O
confirming	O
that	O
the	O
HEK	O
cells	O
survived	O
post	O
-	O
exposure	O
,	O
we	O
then	O
sought	O
to	O
test	O
whether	O
our	O
selected	O
hyperthermic	O
stress	O
protocol	O
induced	O
an	O
appreciable	O
transcriptional	O
stress	O
response	O
To	O
investigate	O
the	O
transcriptional	O
stress	O
response	O
,	O
we	O
exposed	O
HEK	O
cells	O
to	O
hyperthermic	O
stress	O
and	O
used	O
microarray	O
gene	O
chips	O
to	O
quantify	O
the	O
expression	O
level	O
of	O
genes	O
at	O
0	O
,	O
4	O
and	O
24	O
h	O
post	O
-	O
exposure	O
(	O
Figure	O
1A	O
).	O

Since	O
a	O
signature	O
feature	O
of	O
an	O
appreciable	O
stress	O
response	O
is	O
the	O
rapid	O
and	O
marked	O
upregulation	O
of	O
minimal	O
stress	O
genes	O
[	O
12	O
],	O
we	O
conducted	O
microarray	O
and	O
PCR	O
analyses	O
to	O
examine	O
the	O
genes	O
that	O
HEKs	O
express	O
when	O
exposed	O
to	O
hyperthermia	O
(	O
Figure	O
1C	O
,	O
D	O
).	O

Using	O
Ingenuity	O
Pathway	O
Analysis	O
(	O
IPA	O
)	O
software	O
,	O
we	O
filtered	O
the	O
microarray	O
data	O
using	O
the	O
following	O
cut	O
-	O
offs	O
:	O
(	O
i	O
)	O
an	O
absolute	O
value	O
of	O
expression	O
magnitude	O
(	O
log2	O
ratio	O
relative	O
to	O
control	O
)	O
greater	O
or	O
equal	O
to	O
1	O
.	O
5	O
;	O
and	O
(	O
ii	O
)	O
a	O
p	O
-	O
value	O
less	O
than	O
or	O
equal	O
to	O
0	O
.	O
05	O
.	O

Of	O
the	O
54	O
,	O
675	O
probe	O
sets	O
tested	O
on	O
each	O
gene	O
chip	O
,	O
we	O
found	O
that	O
762	O
,	O
1	O
,	O
422	O
and	O
1	O
,	O
478	O
genes	O
were	O
differentially	O
expressed	O
at	O
the	O
0	O
,	O
4	O
and	O
24	O
h	O
time	O
points	O
,	O
respectively	O
(	O
Figure	O
1C	O
).	O

The	O
number	O
of	O
upregulated	O
genes	O
increased	O
in	O
a	O
logarithmic	O
fashion	O
from	O
466	O
at	O
0	O
h	O
,	O
872	O
at	O
4	O
h	O
and	O
up	O
to	O
1	O
,	O
127	O
at	O
24	O
h	O
.	O

Interestingly	O
,	O
roughly	O
60	O
%	O
of	O
the	O
transcripts	O
regulated	O
at	O
0	O
and	O
4	O
h	O
were	O
upregulated	O
,	O
but	O
by	O
24	O
h	O
,	O
~	O
75	O
%	O
of	O
the	O
differentially	O
expressed	O
genes	O
were	O
upregulated	O
.	O

Specifically	O
,	O
we	O
found	O
that	O
the	O
heat	O
-	O
treated	O
groups	O
expressed	O
transcripts	O
for	O
many	O
heat	B-GP
shock	I-GP
proteins	I-GP
(	O
Hsps	B-GP
).	O

We	O
also	O
found	O
that	O
the	O
transcripts	O
encoding	O
for	O
heat	B-GP
shock	I-GP
protein	I-GP
70	I-GP
(	O
HSPA6	B-GP
)	O
exhibited	O
the	O
greatest	O
increase	O
in	O
expression	O
and	O
the	O
highest	O
level	O
of	O
statistical	O
significance	O
.	O

To	O
validate	O
these	O
microarray	O
results	O
,	O
we	O
then	O
conducted	O
qRT	O
-	O
PCR	O
analyses	O
for	O
HSPA6	B-GP
(	O
Hsp70	B-GP
)	O
(	O
Figure	O
1D	O
).	O

For	O
all	O
of	O
the	O
samples	O
tested	O
,	O
we	O
found	O
that	O
the	O
heat	O
-	O
treated	O
treatment	O
group	O
exhibited	O
statistically	O
significant	O
increases	O
in	O
HSPA6	B-GP
expression	O
,	O
ranging	O
between	O
10	O
-	O
and	O
25	O
-	O
fold	O
compared	O
to	O
the	O
sham	O
group	O
.	O

These	O
results	O
were	O
consistent	O
with	O
the	O
microarray	O
data	O
,	O
which	O
showed	O
that	O
HSPA6	B-GP
expression	O
increased	O
between	O
4	O
-	O
and	O
32	O
-	O
fold	O
.	O

2	O
.	O
2	O
.	O

Temporal	O
Gene	O
Expression	O
Profiles	O
for	O
Keratinocytes	O
Exposed	O
To	O
Hyperthermic	O
Stress	O

In	O
order	O
to	O
visualize	O
the	O
global	O
distribution	O
of	O
the	O
gene	O
expression	O
profiles	O
,	O
we	O
then	O
created	O
volcano	O
plots	O
for	O
all	O
genes	O
at	O
each	O
time	O
point	O
.	O

In	O
these	O
plots	O
,	O
the	O
level	O
of	O
statistical	O
significance	O
(	O
p	O
-	O
value	O
)	O
for	O
each	O
gene	O
is	O
plotted	O
versus	O
the	O
fold	O
-	O
change	O
in	O
expression	O
level	O
relative	O
to	O
untreated	O
sham	O
(	O
Figure	O
2	O
).	O

Genes	O
with	O
the	O
highest	O
level	O
of	O
statistical	O
significance	O
appear	O
on	O
the	O
right	O
side	O
of	O
the	O
plot	O
.	O

In	O
addition	O
,	O
upregulated	O
genes	O
that	O
display	O
large	O
-	O
magnitude	O
fold	O
-	O
changes	O
appear	O
towards	O
the	O
top	O
of	O
the	O
plot	O
(	O
denoted	O
with	O
green	O
triangles	O
),	O
whereas	O
downregulated	O
genes	O
appear	O
towards	O
the	O
bottom	O
(	O
denoted	O
with	O
red	O
triangles	O
).	O

We	O
found	O
that	O
considerably	O
more	O
genes	O
were	O
differentially	O
expressed	O
at	O
4	O
h	O
and	O
24	O
h	O
than	O
at	O
the	O
0	O
h	O
time	O
point	O
.	O

We	O
also	O
found	O
that	O
the	O
transcripts	O
expressed	O
at	O
the	O
later	O
time	O
points	O
also	O
exhibited	O
lower	O
p	O
-	O
values	O
and	O
larger	O
-	O
magnitude	O
changes	O
in	O
expression	O
level	O
than	O
the	O
genes	O
at	O
0	O
h	O
.	O

Collectively	O
,	O
our	O
results	O
show	O
that	O
hyperthermic	O
stress	O
triggers	O
a	O
rapid	O
,	O
robust	O
and	O
extensive	O
transcriptional	O
response	O
in	O
HEK	O
cells	O
.	O

The	O
temporal	O
kinetics	O
expression	O
data	O
also	O
show	O
that	O
this	O
stress	O
response	O
is	O
immediately	O
activated	O
in	O
response	O
to	O
stress	O
and	O
is	O
sustained	O
for	O
many	O
hours	O
after	O
exposure	O
.	O

Volcano	O
plots	O
of	O
the	O
gene	O
expression	O
profiles	O
at	O
each	O
time	O
point	O
.	O

The	O
magnitude	O
of	O
differential	O
expression	O
(	O
log2	O
fold	O
-	O
change	O
)	O
is	O
plotted	O
versus	O
the	O
level	O
of	O
statistical	O
significance	O
(	O
p	O
-	O
value	O
)	O
of	O
all	O
genes	O
in	O
the	O
microarray	O
for	O
0	O
,	O
4	O
and	O
24	O
h	O
post	O
-	O
heat	O
exposure	O
.	O

Upregulated	O
and	O
downregulated	O
genes	O
with	O
absolute	O
log2	O
ratios	O
≥	O
1	O
.	O
5	O
and	O
p	O
-	O
values	O
≤	O
0	O
.	O
05	O
are	O
depicted	O
with	O
green	O
and	O
red	O
triangle	O
symbols	O
,	O
respectively	O
.	O

Insignificant	O
genes	O
are	O
denoted	O
with	O
light	O
gray	O
symbols	O
.	O

2	O
.	O
3	O
.	O

Biological	O
Functions	O
of	O
Heat	B-GP
-	I-GP
Shock	I-GP
-	I-GP
Induced	I-GP
Genes	I-GP

After	O
identifying	O
the	O
genes	O
expressed	O
in	O
response	O
to	O
hyperthermic	O
stress	O
,	O
we	O
then	O
used	O
IPA	O
software	O
to	O
identify	O
each	O
gene	O
’	O
s	O
primary	O
biological	O
functions	O
.	O
Figure	O
3	O
contains	O
pie	O
charts	O
of	O
the	O
total	O
number	O
of	O
genes	O
associated	O
with	O
each	O
cellular	O
and	O
molecular	O
function	O
.	O

We	O
found	O
that	O
23	O
biological	O
functions	O
were	O
common	O
to	O
all	O
three	O
time	O
points	O
.	O

Interestingly	O
,	O
only	O
nine	O
functions	O
in	O
this	O
group	O
were	O
either	O
unique	O
to	O
one	O
or	O
shared	O
by	O
two	O
time	O
points	O
(	O
Figure	O
3	O
).	O

In	O
general	O
,	O
the	O
0	O
h	O
and	O
24	O
h	O
time	O
points	O
share	O
many	O
genes	O
with	O
functions	O
required	O
for	O
free	O
radical	O
scavenging	O
,	O
whereas	O
only	O
the	O
4	O
h	O
time	O
point	O
contains	O
genes	O
with	O
functions	O
dedicated	O
primarily	O
to	O
protein	O
regulation	O
(	O
i	O
.	O
e	O
.,	O
protein	O
trafficking	O
and	O
protein	O
folding	O
)	O
(	O
Figure	O
3B	O
).	O

Diagrams	O
of	O
cellular	O
and	O
molecular	O
functions	O
associated	O
with	O
genes	O
expressed	O
in	O
human	B-OG
epidermal	O
keratinocyte	O
(	O
HEK	O
)	O
cells	O
exposed	O
to	O
heat	O
shock	O
.	O

Following	O
an	O
Ingenuity	O
Pathway	O
Analysis	O
(	O
IPA	O
)	O
core	O
analysis	O
,	O
the	O
molecular	O
and	O
cellular	O
functions	O
linked	O
to	O
each	O
recovery	O
period	O
were	O
sorted	O
and	O
illustrated	O
.	O

(	O
A	O
)	O
A	O
list	O
of	O
the	O
23	O
biological	O
functions	O
common	O
to	O
all	O
three	O
time	O
points	O
and	O
nine	O
functions	O
unique	O
to	O
one	O
time	O
point	O
or	O
shared	O
between	O
two	O
time	O
points	O
;	O
(	O
B	O
)	O
Pie	O
charts	O
of	O
gene	O
functions	O
at	O
0	O
,	O
4	O
and	O
24	O
h	O
post	O
-	O
exposure	O
.	O

The	O
pie	O
chart	O
sectors	O
represent	O
the	O
number	O
of	O
genes	O
associated	O
with	O
each	O
function	O
.	O

Next	O
,	O
we	O
identified	O
the	O
biological	O
function	O
groups	O
that	O
had	O
the	O
greatest	O
number	O
of	O
differentially	O
expressed	O
genes	O
.	O

For	O
each	O
time	O
point	O
,	O
we	O
generated	O
color	O
-	O
coded	O
pie	O
charts	O
containing	O
the	O
top	O
five	O
biological	O
functions	O
and	O
the	O
number	O
of	O
genes	O
in	O
each	O
group	O
(	O
Figure	O
4	O
).	O

We	O
found	O
that	O
two	O
biological	O
functions	O
(	O
i	O
.	O
e	O
.,	O
cellular	O
growth	O
and	O
proliferation	O
and	O
cell	O
death	O
)	O
appeared	O
in	O
the	O
top	O
five	O
at	O
each	O
time	O
point	O
.	O

In	O
addition	O
to	O
these	O
functions	O
,	O
the	O
0	O
h	O
and	O
4	O
h	O
time	O
points	O
also	O
shared	O
two	O
more	O
top	O
functions	O
,	O
which	O
are	O
associated	O
with	O
cellular	O
development	O
and	O
gene	O
expression	O
.	O

The	O
only	O
major	O
difference	O
between	O
these	O
time	O
points	O
was	O
that	O
the	O
0	O
h	O
time	O
point	O
had	O
more	O
genes	O
associated	O
with	O
molecular	O
transport	O
,	O
whereas	O
the	O
4	O
h	O
group	O
had	O
more	O
genes	O
involved	O
in	O
cellular	O
movement	O
functions	O
.	O

In	O
contrast	O
,	O
despite	O
exhibiting	O
a	O
similar	O
number	O
of	O
regulated	O
genes	O
,	O
the	O
4	O
h	O
and	O
24	O
h	O
groups	O
only	O
shared	O
three	O
top	O
functions	O
:	O
cellular	O
movement	O
,	O
cell	O
death	O
and	O
cell	O
growth	O
.	O

The	O
primary	O
difference	O
between	O
these	O
time	O
points	O
is	O
that	O
the	O
4	O
h	O
group	O
had	O
more	O
genes	O
dedicated	O
to	O
cellular	O
development	O
and	O
gene	O
expression	O
,	O
whereas	O
the	O
24	O
h	O
group	O
exhibited	O
genes	O
with	O
cellular	O
function	O
and	O
cell	O
cycle	O
processes	O
.	O

Pie	O
chart	O
of	O
the	O
top	O
five	O
cellular	O
and	O
molecular	O
functions	O
at	O
each	O
time	O
point	O
.	O

Each	O
sector	O
of	O
the	O
pie	O
chart	O
represents	O
the	O
total	O
number	O
of	O
genes	O
expressed	O
for	O
each	O
cellular	O
function	O
.	O

Genes	O
were	O
filtered	O
for	O
an	O
absolute	O
value	O
log2	O
ratio	O
≥	O
1	O
.	O
5	O
and	O
a	O
significance	O
value	O
of	O
p	O
≤	O
0	O
.	O
05	O
.	O

2	O
.	O
4	O
.	O

Identification	O
of	O
Shared	O
and	O
Unique	O
Genes	O

We	O
next	O
sought	O
to	O
determine	O
whether	O
any	O
of	O
the	O
differentially	O
expressed	O
genes	O
were	O
observed	O
at	O
all	O
time	O
points	O
.	O

To	O
answer	O
this	O
question	O
,	O
we	O
performed	O
a	O
biomarker	O
filter	O
analysis	O
.	O

This	O
tool	O
allowed	O
us	O
to	O
identify	O
the	O
genes	O
that	O
were	O
unique	O
and	O
shared	O
by	O
each	O
group	O
.	O

The	O
Venn	O
diagram	O
in	O
Figure	O
5	O
shows	O
the	O
total	O
number	O
of	O
genes	O
that	O
were	O
shared	O
and	O
unique	O
to	O
each	O
time	O
point	O
.	O

A	O
total	O
of	O
492	O
,	O
1	O
,	O
066	O
and	O
1	O
,	O
142	O
genes	O
were	O
unique	O
to	O
the	O
0	O
h	O
,	O
4	O
h	O
and	O
24	O
h	O
evaluation	O
groups	O
,	O
respectively	O
.	O

We	O
found	O
that	O
121	O
genes	O
were	O
common	O
to	O
both	O
the	O
0	O
h	O
and	O
4	O
h	O
,	O
107	O
genes	O
to	O
the	O
0	O
h	O
and	O
24	O
h	O
and	O
183	O
genes	O
to	O
the	O
4	O
h	O
and	O
24	O
h	O
.	O

Notably	O
,	O
only	O
50	O
genes	O
were	O
shared	O
among	O
all	O
three	O
recovery	O
time	O
points	O
.	O

A	O
comprehensive	O
list	O
of	O
these	O
genes	O
is	O
provided	O
as	O
supplementary	O
material	O
(	O
Supplementary	O
Tables	O
1	O
–	O
6	O
).	O

Identification	O
of	O
unique	O
and	O
shared	O
genes	O
.	O

The	O
Venn	O
diagram	O
indicates	O
the	O
number	O
of	O
unique	O
and	O
common	O
differentially	O
expressed	O
genes	O
at	O
each	O
time	O
point	O
.	O

Biomarker	O
comparison	O
analysis	O
was	O
performed	O
in	O
IPA	O
.	O

After	O
identifying	O
the	O
50	O
genes	O
that	O
were	O
expressed	O
at	O
each	O
time	O
point	O
,	O
we	O
then	O
performed	O
a	O
series	O
of	O
analyses	O
to	O
better	O
understand	O
the	O
function	O
of	O
each	O
gene	O
.	O

For	O
these	O
analyses	O
,	O
we	O
used	O
the	O
following	O
web	O
-	O
based	O
resources	O
:	O
IPA	O
,	O
GeneCards	O
Human	B-OG
Gene	O
Database	O
,	O
HGNC	O
and	O
Gene	O
Ontology	O
(	O
GO	O
).	O

The	O
pie	O
chart	O
in	O
Figure	O
6	O
contains	O
the	O
symbols	O
for	O
each	O
of	O
the	O
50	O
common	O
genes	O
.	O

This	O
pie	O
chart	O
is	O
also	O
further	O
divided	O
by	O
the	O
family	O
of	O
each	O
gene	O
and	O
the	O
number	O
of	O
genes	O
per	O
family	O
,	O
which	O
is	O
denoted	O
by	O
the	O
number	O
towards	O
the	O
center	O
of	O
each	O
sector	O
of	O
the	O
pie	O
chart	O
.	O

The	O
gene	O
families	O
are	O
color	O
coded	O
and	O
are	O
specified	O
in	O
the	O
legend	O
.	O

The	O
following	O
eight	O
families	O
are	O
provided	O
in	O
the	O
figure	O
:	O
ligand	B-GP
-	I-GP
dependent	I-GP
nuclear	I-GP
receptor	I-GP
,	O
peptidase	B-GP
,	O
phosphatase	B-GP
,	O
transporter	B-GP
,	O
ion	B-GP
channel	I-GP
,	O
kinase	B-GP
,	O
transcription	B-GP
regulator	I-GP
,	O
enzymes	O
and	O
others	O
.	O

The	O
twenty	O
-	O
four	O
genes	O
included	O
in	O
the	O
“	O
other	O
”	O
group	O
consist	O
of	O
genes	O
that	O
were	O
not	O
classified	O
by	O
IPA	O
.	O

Pie	O
chart	O
of	O
50	O
shared	O
biomarkers	O
.	O

Each	O
sector	O
of	O
the	O
pie	O
represents	O
the	O
number	O
of	O
genes	O
associated	O
with	O
each	O
function	O
.	O

The	O
symbols	O
and	O
number	O
of	O
genes	O
are	O
also	O
provided	O
for	O
each	O
function	O
.	O

Genes	O
were	O
filtered	O
for	O
an	O
absolute	O
value	O
log2	O
ratio	O
≥	O
1	O
.	O
5	O
and	O
a	O
significance	O
value	O
of	O
p	O
≤	O
0	O
.	O
05	O
.	O

Next	O
,	O
we	O
sought	O
to	O
examine	O
the	O
temporal	O
expression	O
kinetics	O
for	O
the	O
genes	O
with	O
known	O
biological	O
functions	O
.	O

We	O
found	O
that	O
only	O
44	O
of	O
the	O
50	O
genes	O
identified	O
had	O
well	O
-	O
characterized	O
biological	O
processes	O
and	O
GO	O
annotations	O
.	O
Figure	O
7	O
provides	O
the	O
magnitude	O
of	O
the	O
fold	O
-	O
change	O
in	O
expression	O
for	O
each	O
of	O
these	O
genes	O
as	O
a	O
function	O
of	O
time	O
.	O

The	O
asterisks	O
denote	O
genes	O
that	O
have	O
multiple	O
key	O
biological	O
functions	O
.	O

The	O
genes	O
include	O
the	O
chaperones	B-GP
that	O
function	O
in	O
response	O
to	O
stress	O
and	O
protein	O
unfolding	O
.	O

These	O
genes	O
encode	O
for	O
the	O
following	O
heat	B-GP
shock	I-GP
70	I-GP
kDa	I-GP
proteins	I-GP
:	O
HSPA6	B-GP
,	O
HSPA1L	B-GP
and	O
HSPA1A	B-GP
/	O
A1B	O
.	O

The	O
temporal	O
expression	O
kinetics	O
for	O
the	O
genes	O
with	O
known	O
gene	O
ontology	O
(	O
GO	O
).	O

Asterisks	O
indicate	O
the	O
genes	O
with	O
more	O
than	O
one	O
biological	O
process	O
.	O

Additional	O
genes	O
responsible	O
for	O
the	O
response	O
to	O
stress	O
or	O
heat	O
are	O
CDHR1	B-GP
(	O
cadherin	B-GP
-	I-GP
related	I-GP
family	I-GP
member	I-GP
1	I-GP
),	O
TUB	B-GP
(	O
tubby	B-GP
protein	I-GP
homolog	I-GP
),	O
NOX1	B-GP
(	O
NADPH	B-GP
oxidase	I-GP
1	I-GP
)	O
and	O
IRF1	B-GP
(	O
interferon	B-GP
regulatory	I-GP
factor	I-GP
1	I-GP
).	O

Two	O
genes	O
—	O
PSMB2	B-GP
(	O
proteasome	B-GP
subunit	I-GP
beta	I-GP
type	I-GP
2	I-GP
)	O
and	O
UBA6	B-GP
(	O
ubiquitin	B-GP
-	I-GP
like	I-GP
modifier	I-GP
activating	I-GP
enzyme	I-GP
6	I-GP
)—	O
play	O
roles	O
in	O
protein	O
ubiquitination	O
.	O

CDHR1	B-GP
,	O
ARHGEF40	B-GP
(	O
Rho	B-GP
guanine	I-GP
nucleotide	I-GP
exchange	I-GP
factor	I-GP
(	I-GP
GEF	I-GP
)	I-GP
40	I-GP
),	O
CD9	B-GP
(	O
CD9	B-GP
molecule	O
),	O
DST	B-GP
(	O
dystonin	B-GP
),	O
LRRN2	B-GP
(	O
leucine	B-GP
rich	I-GP
repeat	I-GP
neuronal	I-GP
2	I-GP
)	O
and	O
PCDH11X	B-GP
/	O
Y	O
(	O
protocadherin	B-GP
11	I-GP
Y	I-GP
-	I-GP
linked	I-GP
)	O
support	O
cell	O
adhesion	O
.	O

ALPK1	B-GP
(	O
alpha	B-GP
-	I-GP
kinase	I-GP
1	I-GP
),	O
AGK	B-GP
(	O
acylglycerol	B-GP
kinase	I-GP
),	O
CAMK2B	B-GP
(	O
calcium	B-GP
/	I-GP
calmodulin	I-GP
-	I-GP
dependent	I-GP
protein	I-GP
kinase	I-GP
II	I-GP
beta	I-GP
),	O
MYLK	B-GP
(	O
myosin	B-GP
light	I-GP
chain	I-GP
kinase	I-GP
)	O
and	O
TLK2	B-GP
(	O
tousled	B-GP
-	I-GP
like	I-GP
kinase	I-GP
2	I-GP
)	O
assist	O
in	O
phosphorylation	O
,	O
whereas	O
,	O
GRID1	B-GP
(	O
glutamate	B-GP
receptor	I-GP
delta	I-GP
-	I-GP
1	I-GP
subunit	I-GP
),	O
KCNK10	B-GP
(	O
potassium	B-GP
channel	I-GP
subfamily	I-GP
K	I-GP
member	I-GP
10	I-GP
),	O
ARL4C	B-GP
(	O
ADP	B-GP
-	I-GP
ribosylation	I-GP
factor	I-GP
-	I-GP
like	I-GP
4	I-GP
),	O
HBA1	B-GP
/	O
HBA2	B-GP
(	O
hemoglobin	B-GP
alpha	I-GP
1	I-GP
),	O
PITPNC1	B-GP
(	O
cytoplasmic	B-GP
phosphatidylinositol	I-GP
transfer	I-GP
protein	I-GP
1	I-GP
),	O
CAMK2B	B-GP
and	O
NOX1	B-GP
support	O
the	O
transport	O
function	O
.	O

In	O
addition	O
,	O
CADM2	B-GP
(	O
cell	B-GP
adhesion	I-GP
molecule	I-GP
2	I-GP
),	O
HIST1H2AG	B-GP
(	O
histone	B-GP
cluster	I-GP
1	I-GP
,	I-GP
H2ag	I-GP
),	O
NEBL	B-GP
(	O
nebulette	B-GP
)	O
and	O
IGHA1	B-GP
play	O
roles	O
in	O
junction	O
organization	O
,	O
nucleosome	O
assembly	O
,	O
actin	B-GP
filament	O
length	O
and	O
immune	O
response	O
,	O
respectively	O
.	O

Furthermore	O
,	O
as	O
indicated	O
in	O
Figure	O
7	O
,	O
some	O
of	O
the	O
above	O
mentioned	O
genes	O
and	O
the	O
remaining	O
ones	O
are	O
involved	O
in	O
processes	O
related	O
to	O
homeostasis	O
response	O
.	O

These	O
include	O
regulation	O
of	O
transcription	O
,	O
apoptosis	O
,	O
metabolism	O
and	O
signal	O
transduction	O
related	O
-	O
genes	O
.	O

The	O
gene	O
families	O
related	O
to	O
the	O
unique	O
genes	O
or	O
the	O
genes	O
shared	O
between	O
each	O
two	O
time	O
points	O
,	O
as	O
well	O
as	O
the	O
number	O
of	O
genes	O
per	O
each	O
family	O
are	O
illustrated	O
in	O
the	O
pie	O
charts	O
in	O
Figure	O
8	O
.	O

The	O
gene	O
families	O
included	O
those	O
mentioned	O
for	O
the	O
50	O
common	O
genes	O
in	O
addition	O
to	O
other	O
gene	O
families	O
,	O
such	O
as	O
G	B-GP
-	I-GP
protein	I-GP
coupled	I-GP
receptor	I-GP
,	O
growth	O
factor	O
,	O
cytokine	B-GP
,	O
translation	B-GP
regulator	I-GP
and	O
transmembrane	B-GP
receptor	I-GP
family	O
.	O

The	O
genes	O
classified	O
by	O
IPA	O
as	O
“	O
other	O
”	O
were	O
omitted	O
in	O
this	O
representation	O
.	O

A	O
list	O
of	O
all	O
these	O
genes	O
and	O
fold	O
-	O
change	O
following	O
heat	O
-	O
shock	O
in	O
the	O
different	O
interval	O
of	O
recovery	O
is	O
added	O
as	O
tables	O
in	O
the	O
supplemental	O
materials	O
.	O

Gene	O
family	O
of	O
the	O
genes	O
that	O
are	O
unique	O
or	O
are	O
shared	O
at	O
two	O
time	O
points	O
.	O

The	O
pie	O
chart	O
sectors	O
represent	O
the	O
number	O
of	O
genes	O
associated	O
with	O
each	O
function	O
indicated	O
in	O
the	O
legend	O
.	O

The	O
numbers	O
of	O
these	O
genes	O
are	O
indicated	O
for	O
each	O
function	O
.	O

The	O
genes	O
classified	O
by	O
IPA	O
as	O
“	O
other	O
”	O
were	O
not	O
included	O
in	O
this	O
representation	O
.	O

Genes	O
were	O
filtered	O
for	O
an	O
absolute	O
value	O
log2	O
ratio	O
≥	O
1	O
.	O
5	O
and	O
a	O
significance	O
value	O
of	O
p	O
≤	O
0	O
.	O
05	O
.	O

In	O
Figure	O
9	O
,	O
we	O
highlight	O
a	O
set	O
of	O
genes	O
from	O
the	O
unique	O
genes	O
list	O
that	O
are	O
recognized	O
to	O
play	O
roles	O
in	O
cellular	O
stress	O
response	O
.	O

These	O
include	O
genes	O
involved	O
as	O
heat	B-GP
shock	I-GP
proteins	I-GP
and	O
genes	O
supporting	O
DNA	O
damage	O
and	O
repair	O
,	O
inflammation	O
and	O
apoptosis	O
.	O

Gene	O
expression	O
profiles	O
for	O
a	O
set	O
of	O
unique	O
genes	O
involved	O
in	O
several	O
well	O
-	O
characterized	O
pathways	O
of	O
the	O
cellular	O
stress	O
response	O
.	O

2	O
.	O
5	O
.	O

Pathway	O
Analysis	O
of	O
Microarray	O
Analyzed	O
Data	O

We	O
next	O
used	O
IPA	O
to	O
analyze	O
the	O
metabolic	O
and	O
signaling	O
pathways	O
that	O
are	O
affected	O
in	O
response	O
to	O
heat	O
stress	O
following	O
the	O
three	O
post	O
-	O
heat	O
time	O
points	O
.	O

We	O
found	O
that	O
at	O
0	O
h	O
,	O
33	O
of	O
247	O
canonical	O
pathways	O
were	O
expressed	O
with	O
statistical	O
significance	O
,	O
defined	O
as	O
[(−	O
log	O
(	O
p	O
-	O
value	O
)	O
≥	O
1	O
.	O
3	O
or	O
p	O
-	O
value	O
≤	O
0	O
.	O
05	O
]	O
(	O
Table	O
1	O
).	O

At	O
4	O
h	O
post	O
-	O
heat	O
,	O
19	O
out	O
of	O
198	O
scored	O
Ingenuity	O
Canonical	O
Pathways	O
had	O
significant	O
likelihood	O
(	O
Table	O
2	O
).	O

At	O
24	O
h	O
post	O
-	O
heat	O
,	O
IPA	O
scored	O
229	O
Ingenuity	O
Canonical	O
Pathways	O
,	O
of	O
which	O
36	O
had	O
significant	O
p	O
-	O
values	O
(	O
Table	O
3	O
).	O

Significant	O
canonical	O
pathways	O
at	O
0	O
h	O
post	O
-	O
heat	O
exposure	O
.	O

Two	O
-	O
hundred	O
seventy	O
-	O
four	O
Ingenuity	O
Canonical	O
Pathways	O
were	O
scored	O
at	O
0	O
h	O
post	O
-	O
heat	O
exposure	O
;	O
only	O
the	O
33	O
listed	O
pathways	O
fit	O
the	O
cut	O
-	O
off	O
of	O
p	O
-	O
value	O
≤	O
0	O
.	O
05	O
.	O

Ingenuity	O
Canonical	O
Pathways	O

−	O
log	O
(	O
p	O
-	O
value	O
)	O

Ratio	O

#	O
of	O
Molecules	O

IL	B-GP
-	I-GP
12	I-GP
Signaling	O
and	O
Production	O
in	O
Macrophages	O

4	O
.	O
66	O

0	O
.	O
118	O

16	O

Glucocorticoid	B-GP
Receptor	I-GP
Signaling	O

1	O
.	O
83	O

0	O
.	O
061	O

16	O

Role	O
of	O
Macrophages	O
,	O
Fibroblasts	O
and	O
Endothelial	O
Cells	O
in	O
Rheumatoid	B-DS
Arthritis	I-DS

1	O
.	O
41	O

0	O
.	O
054	O

16	O

Production	O
of	O
Nitric	O
Oxide	O
and	O
Reactive	O
Oxygen	O
Species	O
in	O
Macrophages	O

1	O
.	O
85	O

0	O
.	O
070	O

13	O

Clathrin	B-GP
-	O
Mediated	O
Endocytosis	O
Signaling	O

1	O
.	O
80	O

0	O
.	O
069	O

13	O

Dopamine	O
-	O
DARPP32	B-GP
Feedback	O
in	O
cAMP	O
Signaling	O

1	O
.	O
46	O

0	O
.	O
067	O

11	O

NF	B-GP
-	I-GP
κB	I-GP
Signaling	O

1	O
.	O
42	O

0	O
.	O
065	O

11	O

RAR	O
Activation	O

1	O
.	O
35	O

0	O
.	O
063	O

11	O

Neuropathic	O
Pain	O
Signaling	O
in	O
Dorsal	O
Horn	O
Neurons	O

2	O
.	O
35	O

0	O
.	O
094	O

10	O

Type	O
II	O
Diabetes	O
Mellitus	O
Signaling	O

2	O
.	O
07	O

0	O
.	O
079	O

10	O

Virus	B-OG
Entry	O
via	O
Endocytic	O
Pathways	O

2	O
.	O
28	O

0	O
.	O
098	O

9	O

Synaptic	O
Long	O
-	O
Term	O
Potentiation	O

1	O
.	O
88	O

0	O
.	O
087	O

9	O

fMLP	O
Signaling	O
in	O
Neutrophils	O

1	O
.	O
78	O

0	O
.	O
077	O

9	O

PKCθ	B-GP
Signaling	O
in	O
T	O
-	O
lymphocytes	O

1	O
.	O
64	O

0	O
.	O
071	O

9	O

Role	O
of	O
Pattern	B-GP
Recognition	I-GP
Receptors	I-GP
in	O
Recognition	O
of	O
Bacteria	B-OG
and	O
Viruses	B-OG

2	O
.	O
29	O

0	O
.	O
104	O

8	O

T	O
-	O
cell	O
Receptor	O
Signaling	O

1	O
.	O
61	O

0	O
.	O
078	O

8	O

iCOS	B-GP
-	O
iCOSL	B-GP
Signaling	O
in	O
T	O
Helper	O
Cells	O

1	O
.	O
45	O

0	O
.	O
071	O

8	O

Rac	B-GP
Signaling	O

1	O
.	O
45	O

0	O
.	O
068	O

8	O

Pancreatic	B-DS
Adenocarcinoma	I-DS
Signaling	O

1	O
.	O
41	O

0	O
.	O
070	O

8	O

Renin	B-GP
-	O
Angiotensin	O
Signaling	O

1	O
.	O
33	O

0	O
.	O
070	O

8	O

Erythropoietin	O
Signaling	O

1	O
.	O
95	O

0	O
.	O
095	O

7	O

Macropinocytosis	O
Signaling	O

1	O
.	O
92	O

0	O
.	O
092	O

7	O

NF	B-GP
-	I-GP
κB	I-GP
Activation	O
by	O
Viruses	B-OG

1	O
.	O
76	O

0	O
.	O
089	O

7	O

Ceramide	O
Signaling	O

1	O
.	O
62	O

0	O
.	O
085	O

7	O

RANK	B-GP
Signaling	O
in	O
Osteoclasts	O

1	O
.	O
42	O

0	O
.	O
076	O

7	O

Calcium	O
-	O
induced	O
T	O
-	O
lymphocyte	O
Apoptosis	O

1	O
.	O
72	O

0	O
.	O
098	O

6	O

Growth	B-GP
Hormone	I-GP
Signaling	O

1	O
.	O
42	O

0	O
.	O
085	O

6	O

Complement	O
System	O

2	O
.	O
24	O

0	O
.	O
152	O

5	O

MSP	B-GP
-	O
RON	B-GP
Signaling	O
Pathway	O

1	O
.	O
66	O

0	O
.	O
109	O

5	O

Cell	O
Cycle	O
:	O
G1	O
/	O
S	O
Checkpoint	O
Regulation	O

1	O
.	O
33	O

0	O
.	O
085	O

5	O

Role	O
of	O
CHK	B-GP
Proteins	O
in	O
Cell	O
Cycle	O
Checkpoint	O
Control	O

1	O
.	O
50	O

0	O
.	O
114	O

4	O

IL	B-GP
-	I-GP
9	I-GP
Signaling	O

1	O
.	O
46	O

0	O
.	O
105	O

4	O

April	B-GP
Mediated	O
Signaling	O

1	O
.	O
31	O

0	O
.	O
095	O

4	O

Significant	O
canonical	O
pathways	O
in	O
4	O
h	O
post	O
-	O
heat	O
exposure	O
.	O

198	O
Ingenuity	O
Canonical	O
Pathways	O
were	O
scored	O
at	O
4	O
h	O
post	O
-	O
heat	O
exposure	O
;	O
only	O
the	O
19	O
listed	O
pathways	O
fit	O
the	O
cut	O
-	O
off	O
of	O
p	O
-	O
value	O
≤	O
0	O
.	O
05	O
.	O

Ingenuity	O
Canonical	O
Pathways	O

−	O
log	O
(	O
p	O
-	O
value	O
)	O

Ratio	O

#	O
of	O
Molecules	O

Leukocyte	O
Extravasation	O
Signaling	O

2	O
.	O
58	O

0	O
.	O
127	O

24	O

Huntington	O
’	O
s	O
Disease	O
Signaling	O

2	O
.	O
39	O

0	O
.	O
114	O

26	O

Tight	O
Junction	O
Signaling	O

2	O
.	O
34	O

0	O
.	O
127	O

20	O

Bladder	B-DS
Cancer	I-DS
Signaling	O

2	O
.	O
15	O

0	O
.	O
144	O

13	O

VDR	O
/	O
RXR	B-GP
Activation	O

2	O
.	O
12	O

0	O
.	O
152	O

12	O

ATM	B-GP
Signaling	O

2	O
.	O
04	O

0	O
.	O
167	O

9	O

Coagulation	O
System	O

2	O
.	O
02	O

0	O
.	O
200	O

7	O

Colorectal	B-DS
Cancer	I-DS
Metastasis	O
Signaling	O

1	O
.	O
90	O

0	O
.	O
107	O

26	O

Wnt	B-GP
/	O
β	O
-	O
catenin	O
Signaling	O

1	O
.	O
90	O

0	O
.	O
118	O

20	O

Cyclins	B-GP
and	O
Cell	O
Cycle	O
Regulation	O

1	O
.	O
76	O

0	O
.	O
126	O

11	O

Role	O
of	O
Macrophages	O
,	O
Fibroblasts	O
and	O
Endothelial	O
Cells	O
in	O
Rheumatoid	B-DS
Arthritis	I-DS

1	O
.	O
70	O

0	O
.	O
096	O

30	O

Nur77	B-GP
Signaling	O
in	O
T	O
-	O
lymphocytes	O

1	O
.	O
62	O

0	O
.	O
140	O

8	O

IL	B-GP
-	I-GP
17A	I-GP
Signaling	O
in	O
Gastric	O
Cells	O

1	O
.	O
57	O

0	O
.	O
200	O

5	O

Cell	O
Cycle	O
:	O
G1	O
/	O
S	O
Checkpoint	O
Regulation	O

1	O
.	O
49	O

0	O
.	O
136	O

8	O

IL	B-GP
-	I-GP
17A	I-GP
Signaling	O
in	O
Fibroblasts	O

1	O
.	O
49	O

0	O
.	O
154	O

6	O

Nitrogen	O
Metabolism	O

1	O
.	O
49	O

0	O
.	O
171	O

6	O

Production	O
of	O
Nitric	O
Oxide	O
and	O
Reactive	O
Oxygen	O
Species	O
in	O
Macrophages	O

1	O
.	O
37	O

0	O
.	O
103	O

19	O

Ceramide	O
Signaling	O

1	O
.	O
35	O

0	O
.	O
122	O

10	O

Aldosterone	O
Signaling	O
in	O
Epithelial	O
Cells	O

1	O
.	O
35	O

0	O
.	O
106	O

17	O

Significant	O
canonical	O
pathways	O
at	O
24	O
h	O
post	O
-	O
heat	O
exposure	O
.	O

229	O
Ingenuity	O
Canonical	O
Pathways	O
were	O
scored	O
at	O
24	O
h	O
post	O
-	O
heat	O
exposure	O
;	O
only	O
the	O
36	O
listed	O
pathways	O
fit	O
the	O
cut	O
-	O
off	O
of	O
p	O
-	O
value	O
≤	O
0	O
.	O
05	O
.	O

Ingenuity	O
Canonical	O
Pathways	O

−	O
log	O
(	O
p	O
-	O
value	O
)	O

Ratio	O

#	O
of	O
Molecules	O

Aryl	B-GP
Hydrocarbon	I-GP
Receptor	I-GP
Signaling	O

4	O
.	O
33	O

0	O
.	O
170	O

23	O

Linoleic	O
Acid	O
Metabolism	O

2	O
.	O
78	O

0	O
.	O
197	O

11	O

Role	O
of	O
IL	B-GP
-	I-GP
17A	I-GP
in	O
Psoriasis	B-DS

2	O
.	O
74	O

0	O
.	O
385	O

4	O

Bladder	B-DS
Cancer	I-DS
Signaling	O

2	O
.	O
72	O

0	O
.	O
167	O

14	O

Oncostatin	O
M	O
Signaling	O

2	O
.	O
52	O

0	O
.	O
235	O

7	O

TREM1	O
Signaling	O

2	O
.	O
39	O

0	O
.	O
189	O

9	O

Cell	O
Cycle	O
:	O
G1	O
/	O
S	O
Checkpoint	O
Regulation	O

2	O
.	O
21	O

0	O
.	O
169	O

9	O

Fcγ	B-GP
Receptor	I-GP
-	O
mediated	O
Phagocytosis	O
in	O
Macrophages	O
and	O
Monocytes	O

2	O
.	O
08	O

0	O
.	O
149	O

13	O

Role	O
of	O
CHK	B-GP
Proteins	O
in	O
Cell	O
Cycle	O
Checkpoint	O
Control	O

2	O
.	O
00	O

0	O
.	O
200	O

6	O

Glucocorticoid	B-GP
Receptor	I-GP
Signaling	O

1	O
.	O
94	O

0	O
.	O
108	O

29	O

Atherosclerosis	O
Signaling	O

1	O
.	O
90	O

0	O
.	O
128	O

15	O

Cell	O
Cycle	O
:	O
G2	O
/	O
M	O
DNA	O
Damage	O
Checkpoint	O
Regulation	O

1	O
.	O
88	O

0	O
.	O
167	O

7	O

Amino	O
sugars	O
Metabolism	O

1	O
.	O
88	O

0	O
.	O
159	O

10	O

Metabolism	O
of	O
Xenobiotics	O
by	O
Cytochrome	B-GP
P450	I-GP

1	O
.	O
86	O

0	O
.	O
148	O

12	O

IL	B-GP
-	I-GP
8	I-GP
Signaling	O

1	O
.	O
77	O

0	O
.	O
118	O

20	O

Airway	O
Pathology	O
in	O
Chronic	B-DS
Obstructive	I-DS
Pulmonary	I-DS
Disease	I-DS

1	O
.	O
75	O

0	O
.	O
375	O

2	O

LPS	O
/	O
IL	B-GP
-	I-GP
1	I-GP
Mediated	O
Inhibition	O
of	O
RXR	B-GP
Function	O

1	O
.	O
74	O

0	O
.	O
112	O

22	O

Chronic	O
Myeloid	O
Leukemia	O
Signaling	O

1	O
.	O
71	O

0	O
.	O
127	O

12	O

Arachidonic	O
Acid	O
Metabolism	O

1	O
.	O
71	O

0	O
.	O
137	O

13	O

Sphingosine	O
-	O
1	O
-	O
phosphate	O
Signaling	O

1	O
.	O
70	O

0	O
.	O
126	O

14	O

Hereditary	O
Breast	O
Cancer	O
Signaling	O

1	O
.	O
67	O

0	O
.	O
125	O

14	O

Leukocyte	O
Extravasation	O
Signaling	O

1	O
.	O
66	O

0	O
.	O
116	O

21	O

Role	O
of	O
BRCA1	B-GP
in	O
DNA	O
Damage	O
Response	O

1	O
.	O
65	O

0	O
.	O
153	O

8	O

Pancreatic	B-DS
Adenocarcinoma	I-DS
Signaling	O

1	O
.	O
61	O

0	O
.	O
123	O

13	O

Role	O
of	O
IL	B-GP
-	I-GP
17F	I-GP
in	O
Allergic	B-DS
Inflammatory	I-DS
Airway	I-DS
Diseases	I-DS

1	O
.	O
56	O

0	O
.	O
167	O

6	O

IL	B-GP
-	I-GP
10	I-GP
Signaling	O

1	O
.	O
53	O

0	O
.	O
139	O

9	O

IL	B-GP
-	I-GP
22	I-GP
Signaling	O

1	O
.	O
52	O

0	O
.	O
208	O

4	O

Cellular	O
Effects	O
of	O
Sildenafil	O
(	O
Viagra	O
)	O

1	O
.	O
47	O

0	O
.	O
121	O

15	O

Inhibition	O
of	O
Angiogenesis	O
by	O
TSP1	B-GP

1	O
.	O
47	O

0	O
.	O
182	O

5	O

Role	O
of	O
JAK	B-GP
Family	O
Kinases	B-GP
in	O
IL	B-GP
-	I-GP
6	I-GP
-	I-GP
type	I-GP
Cytokine	I-GP
Signaling	O

1	O
.	O
45	O

0	O
.	O
192	O

4	O

Tryptophan	O
Metabolism	O

1	O
.	O
45	O

0	O
.	O
127	O

13	O

Purine	O
Metabolism	O

1	O
.	O
41	O

0	O
.	O
106	O

27	O

Parkinson	O
’	O
s	O
Signaling	O

1	O
.	O
39	O

0	O
.	O
222	O

3	O

p53	O
Signaling	O

1	O
.	O
35	O

0	O
.	O
126	O

11	O

cAMP	O
-	O
Mediated	O
Signaling	O

1	O
.	O
33	O

0	O
.	O
107	O

22	O

IL	B-GP
-	I-GP
15	I-GP
Production	O

1	O
.	O
32	O

0	O
.	O
172	O

4	O

Subsequently	O
,	O
in	O
order	O
to	O
highlight	O
the	O
pathways	O
more	O
relevant	O
to	O
cellular	O
stress	O
response	O
,	O
we	O
further	O
refined	O
our	O
analysis	O
by	O
excluding	O
signaling	O
pathway	O
categories	O
,	O
such	O
as	O
cancer	B-DS
,	O
cardiovascular	O
and	O
nervous	O
system	O
signaling	O
,	O
toxicity	O
list	O
and	O
disease	O
-	O
specific	O
pathways	O
,	O
in	O
addition	O
to	O
non	O
-	O
skin	O
cell	O
-	O
type	O
-	O
specific	O
canonical	O
pathways	O
.	O
Figure	O
10	O
shows	O
a	O
refined	O
presentation	O
of	O
the	O
top	O
canonical	O
pathways	O
for	O
each	O
post	O
-	O
heat	O
recovery	O
time	O
point	O
.	O

For	O
the	O
cell	O
cycle	O
,	O
the	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
pathway	O
was	O
affected	O
in	O
all	O
three	O
time	O
points	O
.	O
The	O
ceramide	O
signaling	O
pathway	O
was	O
affected	O
in	O
both	O
0	O
h	O
and	O
4	O
h	O
.	O

The	O
glucocorticoid	B-GP
receptor	I-GP
signaling	O
pathway	O
and	O
role	O
of	O
CHK	B-GP
proteins	O
in	O
cell	O
cycle	O
checkpoint	O
control	O
were	O
affected	O
in	O
both	O
0	O
h	O
and	O
24	O
h	O
.	O

All	O
the	O
remaining	O
canonical	O
pathways	O
involved	O
were	O
exclusive	O
to	O
a	O
particular	O
time	O
point	O
.	O

Notably	O
,	O
although	O
most	O
of	O
the	O
canonical	O
pathways	O
in	O
each	O
post	O
-	O
heat	O
time	O
point	O
were	O
unique	O
,	O
they	O
actually	O
serve	O
overlapping	O
top	O
cellular	O
functions	O
.	O

The	O
canonical	O
pathways	O
playing	O
a	O
role	O
in	O
cellular	O
function	O
and	O
maintenance	O
that	O
were	O
affected	O
in	O
0	O
h	O
post	O
-	O
heat	O
consisted	O
of	O
MSP	B-GP
-	O
RON	B-GP
signaling	O
,	O
Rac	B-GP
signaling	O
pathways	O
and	O
two	O
endocytosis	O
pathways	O
.	O

Both	O
endocytosis	O
pathways	O
,	O
namely	O
,	O
macropinocytosis	O
and	O
clathrin	B-GP
-	O
mediated	O
endocytosis	O
signaling	O
pathways	O
,	O
play	O
important	O
roles	O
in	O
plasma	O
membrane	O
reorganization	O
,	O
internalization	O
of	O
extracellular	O
molecules	O
and	O
in	O
transduction	O
of	O
signals	O
within	O
the	O
cell	O
and	O
between	O
cells	O
.	O

Deregulation	O
of	O
seven	O
and	O
13	O
genes	O
in	O
macropinocytosis	O
signaling	O
and	O
clathrin	B-GP
-	O
mediated	O
endocytosis	O
signaling	O
,	O
respectively	O
,	O
starting	O
0	O
h	O
post	O
-	O
heat	O
,	O
implicate	O
an	O
immediate	O
effect	O
of	O
heat	O
shock	O
on	O
the	O
plasma	O
membrane	O
and	O
signal	O
transduction	O
.	O

Macropinocytosis	O
depends	O
on	O
signaling	O
to	O
the	O
actin	B-GP
cytoskeleton	O
,	O
such	O
as	O
the	O
Rac	B-GP
signaling	O
pathway	O
,	O
which	O
was	O
also	O
affected	O
at	O
0	O
h	O
post	O
-	O
heat	O
,	O
with	O
eight	O
deregulated	O
genes	O
,	O
including	O
the	O
Rac	B-GP
activator	O
,	O
TIAM1	B-GP
(	O
T	B-GP
-	I-GP
lymphoma	I-GP
invasion	I-GP
and	I-GP
metastasis	I-GP
1	I-GP
).	O

Immediately	O
,	O
TIAM1	B-GP
mRNA	O
showed	O
more	O
than	O
a	O
4	O
-	O
fold	O
increase	O
.	O

Interestingly	O
,	O
TIAM1	B-GP
has	O
been	O
reported	O
to	O
prevent	O
cell	O
death	O
in	O
heat	O
-	O
stressed	O
wild	O
-	O
type	O
murine	O
keratinocytes	O
,	O
since	O
the	O
TIAM1	B-GP
knock	O
-	O
out	O
cells	O
displayed	O
increased	O
apoptosis	O
[	O
20	O
].	O

Classification	O
of	O
differentially	O
expressed	O
genes	O
into	O
various	O
cellular	O
stress	O
response	O
implicated	O
canonical	O
pathways	O
.	O

The	O
[−	O
log	O
(	O
p	O
-	O
value	O
)]	O
is	O
the	O
maximum	O
p	O
-	O
value	O
for	O
all	O
of	O
the	O
genes	O
in	O
each	O
particular	O
canonical	O
pathway	O
family	O
.	O

The	O
ratio	O
plot	O
indicates	O
the	O
number	O
of	O
the	O
genes	O
expressed	O
at	O
each	O
time	O
point	O
relative	O
to	O
the	O
total	O
number	O
of	O
genes	O
in	O
that	O
particular	O
canonical	O
pathway	O
group	O
.	O

Of	O
the	O
canonical	O
pathways	O
affected	O
at	O
4	O
h	O
post	O
-	O
heat	O
,	O
tight	O
junction	O
signaling	O
plays	O
a	O
role	O
in	O
cellular	O
function	O
and	O
maintenance	O
,	O
whereas	O
those	O
affected	O
at	O
24	O
h	O
post	O
-	O
heat	O
included	O
amino	O
sugar	O
metabolism	O
and	O
cAMP	O
-	O
mediated	O
signaling	O
pathways	O
.	O

The	O
latter	O
is	O
also	O
important	O
in	O
controlling	O
cellular	O
assembly	O
and	O
organization	O
in	O
addition	O
to	O
post	O
-	O
translational	O
modification	O
.	O

Notably	O
,	O
tight	O
junction	O
signaling	O
also	O
plays	O
a	O
role	O
in	O
cellular	O
assembly	O
and	O
organization	O
in	O
addition	O
to	O
cell	O
-	O
to	O
-	O
cell	O
signaling	O
and	O
interaction	O
.	O

The	O
0	O
h	O
time	O
-	O
point	O
post	O
-	O
heat	O
affected	O
pathways	O
playing	O
roles	O
in	O
the	O
regulation	O
of	O
cellular	O
development	O
and	O
/	O
or	O
in	O
cellular	O
growth	O
and	O
proliferation	O
comprised	O
cell	O
cycle	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
,	O
the	O
glucocorticoid	B-GP
receptor	I-GP
,	O
IL	B-GP
-	I-GP
9	I-GP
,	O
NF	B-GP
-	I-GP
κB	I-GP
,	O
April	B-GP
-	O
mediated	O
and	O
growth	B-GP
hormone	I-GP
signaling	O
.	O

The	O
24	O
h	O
post	O
-	O
heat	O
assessment	O
showed	O
that	O
pathways	O
regulating	O
these	O
functions	O
are	O
the	O
cell	O
cycle	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
,	O
the	O
glucocorticoid	B-GP
receptor	I-GP
,	O
IL	B-GP
-	I-GP
10	I-GP
signaling	O
,	O
the	O
role	O
of	O
JAK	B-GP
family	O
kinases	B-GP
in	O
IL	B-GP
-	I-GP
6	I-GP
-	I-GP
type	I-GP
cytokine	I-GP
signaling	O
and	O
purine	O
metabolism	O
,	O
while	O
affected	O
pathways	O
at	O
4	O
h	O
post	O
-	O
heat	O
included	O
cell	O
cycle	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
only	O
.	O

The	O
cell	O
cycle	O
control	O
function	O
is	O
regulated	O
by	O
two	O
pathways	O
at	O
0	O
h	O
post	O
-	O
heat	O
,	O
namely	O
cell	O
cycle	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
and	O
growth	B-GP
hormone	I-GP
signaling	O
.	O

Whereas	O
,	O
four	O
of	O
the	O
canonical	O
pathways	O
affected	O
at	O
4	O
h	O
post	O
-	O
heat	O
(	O
ATM	B-GP
signaling	O
,	O
cyclins	B-GP
,	O
cell	O
cycle	O
regulation	O
,	O
nitrogen	O
metabolism	O
and	O
cell	O
cycle	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
)	O
function	O
in	O
the	O
control	O
of	O
cell	O
cycle	O
progression	O
.	O

Six	O
of	O
the	O
17	O
canonical	O
pathways	O
affected	O
at	O
24	O
h	O
post	O
-	O
heat	O
play	O
a	O
role	O
in	O
cell	O
cycle	O
control	O
.	O

These	O
are	O
aryl	B-GP
hydrocarbon	I-GP
receptor	I-GP
signaling	O
,	O
cell	O
cycle	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
,	O
the	O
role	O
of	O
CHK	B-GP
proteins	O
in	O
cell	O
cycle	O
checkpoint	O
control	O
,	O
cell	O
cycle	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulation	O
and	O
the	O
two	O
metabolic	O
pathways	O
,	O
linoleic	O
acid	O
metabolism	O
and	O
tryptophan	O
metabolism	O
.	O

Cell	O
death	O
,	O
on	O
the	O
other	O
hand	O
,	O
is	O
controlled	O
by	O
the	O
ceramide	O
signaling	O
pathway	O
that	O
was	O
affected	O
at	O
0	O
and	O
4	O
h	O
post	O
-	O
heat	O
and	O
by	O
the	O
related	O
sphingosine	O
-	O
1	O
-	O
phosphate	O
signaling	O
pathway	O
,	O
as	O
well	O
as	O
by	O
the	O
aryl	B-GP
hydrocarbon	I-GP
receptor	I-GP
signaling	O
and	O
cell	O
cycle	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulation	O
,	O
which	O
were	O
affected	O
at	O
24	O
h	O
post	O
-	O
heat	O
.	O

Interestingly	O
,	O
the	O
canonical	O
pathways	O
involved	O
in	O
inflammatory	O
response	O
were	O
only	O
affected	O
at	O
24	O
h	O
post	O
-	O
heat	O
.	O

They	O
consist	O
of	O
IL	B-GP
-	I-GP
10	I-GP
and	O
IL	B-GP
-	I-GP
22	I-GP
signaling	O
.	O

The	O
DNA	O
replication	O
,	O
recombination	O
and	O
repair	O
function	O
involves	O
the	O
role	O
of	O
CHK	B-GP
proteins	O
in	O
cell	O
cycle	O
checkpoint	O
control	O
that	O
was	O
affected	O
at	O
4	O
h	O
and	O
24	O
h	O
post	O
-	O
heat	O
,	O
the	O
ATM	B-GP
signaling	O
pathway	O
that	O
was	O
affected	O
at	O
4	O
h	O
post	O
-	O
heat	O
only	O
and	O
cell	O
cycle	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulation	O
that	O
was	O
affected	O
at	O
24	O
h	O
post	O
-	O
heat	O
only	O
.	O

3	O
.	O

Experimental	O
Section	O

3	O
.	O
1	O
.	O

Cell	O
Culture	O
Conditions	O
and	O
Hyperthermia	O
Stress	O
Protocol	O

HEK	O
were	O
cultured	O
in	O
EpiLife	O
®	O
medium	O
containing	O
supplement	O
S7	O
,	O
as	O
per	O
the	O
manufacturer	O
’	O
s	O
recommendations	O
(	O
Life	O
Technologies	O
).	O

For	O
the	O
heat	O
-	O
shock	O
experiment	O
,	O
cells	O
were	O
put	O
in	O
1	O
.	O
7	O
mL	O
tubes	O
(	O
1	O
.	O
0	O
×	O
106	O
cells	O
/	O
tube	O
)	O
that	O
were	O
sealed	O
with	O
Para	O
-	O
film	O
®	O
and	O
placed	O
in	O
a	O
circulating	O
water	O
bath	O
at	O
44	O
°	O
C	O
for	O
40	O
min	O
.	O

No	O
significant	O
change	O
in	O
pH	O
was	O
observed	O
.	O

Following	O
hyperthermia	O
,	O
cells	O
were	O
either	O
harvested	O
within	O
5	O
min	O
or	O
were	O
first	O
allowed	O
to	O
recover	O
in	O
the	O
incubator	O
at	O
37	O
°	O
C	O
/	O
95	O
%	O
humidity	O
/	O
5	O
%	O
CO2	O
for	O
4	O
h	O
or	O
for	O
24	O
h	O
.	O

Control	O
cells	O
harvested	O
alongside	O
the	O
heat	O
-	O
treated	O
cells	O
were	O
also	O
put	O
in	O
1	O
.	O
7	O
mL	O
tubes	O
(	O
1	O
.	O
0	O
×	O
106	O
cells	O
/	O
tube	O
),	O
but	O
were	O
maintained	O
at	O
all	O
time	O
in	O
an	O
incubator	O
at	O
37	O
°	O
C	O
/	O
95	O
%	O
humidity	O
/	O
5	O
%	O
CO2	O
.	O

3	O
.	O
2	O
.	O

Cellular	O
Viability	O
Assays	O

Viability	O
was	O
evaluated	O
at	O
different	O
post	O
-	O
exposure	O
time	O
points	O
using	O
MTT	O
(	O
3	O
-(	O
4	O
,	O
5	O
-	O
dimethylthiazol	O
-	O
2	O
-	O
yl	O
)-	O
2	O
,	O
5	O
-	O
diphenyltetrazolium	O
bromide	O
)	O
assays	O
(	O
ATCC	O
,	O
Manassas	O
,	O
VA	O
,	O
USA	O
).	O

In	O
brief	O
,	O
HEKs	O
were	O
exposed	O
to	O
hyperthermic	O
stress	O
,	O
then	O
were	O
incubated	O
for	O
5	O
min	O
(	O
0	O
h	O
post	O
-	O
heat	O
),	O
4	O
h	O
(	O
4	O
h	O
post	O
-	O
heat	O
)	O
or	O
24	O
h	O
(	O
24	O
h	O
post	O
-	O
heat	O
).	O

Subsequently	O
,	O
MTT	O
reagents	O
and	O
detergents	O
were	O
added	O
,	O
as	O
per	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

Absorbance	O
readings	O
were	O
measured	O
at	O
570	O
nm	O
with	O
a	O
Synergy	O
HT	O
Plate	O
Reader	O
(	O
Biotech	O
,	O
Winooski	O
,	O
VT	O
,	O
USA	O
).	O

Absorbance	O
readings	O
were	O
also	O
measured	O
for	O
a	O
ladder	O
of	O
serial	O
dilutions	O
(	O
103	O
–	O
106	O
cells	O
)	O
in	O
culture	O
medium	O
.	O

Absorbance	O
values	O
were	O
plotted	O
versus	O
the	O
cell	O
number	O
,	O
and	O
these	O
curves	O
were	O
used	O
to	O
determine	O
the	O
number	O
of	O
viable	O
cells	O
in	O
each	O
well	O
.	O

3	O
.	O
3	O
.	O

RNA	O
Isolation	O
and	O
Normalization	O

RNA	O
was	O
extracted	O
from	O
the	O
heat	O
-	O
treated	O
and	O
control	O
cells	O
using	O
a	O
RNeasy	O
Mini	O
-	O
Kit	O
(	O
Qiagen	O
),	O
according	O
to	O
the	O
manufactures	O
instructions	O
.	O

RNA	O
extraction	O
was	O
performed	O
at	O
three	O
different	O
time	O
intervals	O
as	O
follows	O
:	O
within	O
5	O
min	O
following	O
heat	O
-	O
shock	O
(	O
0	O
h	O
post	O
-	O
heat	O
),	O
after	O
a	O
4	O
h	O
recovery	O
period	O
at	O
37	O
°	O
C	O
(	O
4	O
h	O
post	O
-	O
heat	O
)	O
or	O
after	O
a	O
24	O
h	O
recovery	O
period	O
at	O
37	O
°	O
C	O
(	O
24	O
h	O
post	O
-	O
heat	O
).	O

At	O
each	O
time	O
point	O
,	O
the	O
RNA	O
concentration	O
was	O
assessed	O
on	O
a	O
NanoDrop	O
Spectrophotometer	O
(	O
NanoDrop	O
Technologies	O
),	O
and	O
the	O
quality	O
was	O
measured	O
on	O
a	O
2100	O
Bioanalyzer	O
™	O
(	O
Agilent	O
Technologies	O
).	O

RNA	O
samples	O
with	O
a	O
RNA	O
Integrity	O
Number	O
greater	O
than	O
9	O
.	O
5	O
were	O
subjected	O
to	O
microarray	O
analysis	O
.	O

3	O
.	O
4	O
.	O

Microarray	O
Data	O
Analysis	O

Expression	O
analysis	O
was	O
performed	O
for	O
each	O
time	O
point	O
in	O
triplicates	O
(	O
three	O
control	O
and	O
three	O
heat	O
-	O
shock	O
treated	O
)	O
using	O
the	O
Affymetrix	O
GeneChip	O
®	O
Human	B-OG
Genome	O
U133	O
(	O
HG	O
-	O
U133	O
)	O
plus	O
2	O
.	O
0	O
Array	O
that	O
contains	O
54	O
,	O
675	O
probe	O
sets	O
.	O

Briefly	O
,	O
two	O
micrograms	O
of	O
RNA	O
were	O
used	O
for	O
preparation	O
of	O
biotin	O
-	O
labeled	O
targets	O
(	O
cRNA	O
)	O
using	O
MessageAmp	O
™-	O
based	O
protocols	O
(	O
Ambion	O
,	O
Inc	O
.).	O

Labeled	O
cRNA	O
was	O
fragmented	O
(	O
0	O
.	O
5	O
μg	O
/	O
μL	O
per	O
reaction	O
)	O
and	O
was	O
used	O
for	O
array	O
hybridization	O
and	O
washing	O
.	O

The	O
cRNA	O
was	O
mixed	O
with	O
a	O
hybridization	O
cocktail	O
,	O
heated	O
to	O
99	O
°	O
C	O
for	O
5	O
min	O
and	O
then	O
incubated	O
at	O
45	O
°	O
C	O
for	O
5	O
min	O
.	O

Hybridization	O
arrays	O
were	O
conducted	O
for	O
16	O
h	O
in	O
an	O
Affymetrix	O
Model	O
640	O
hybridization	O
oven	O
(	O
45	O
°	O
C	O
,	O
60	O
rpm	O
).	O

Arrays	O
were	O
washed	O
and	O
stained	O
on	O
an	O
FS450	O
Fluidics	O
station	O
and	O
were	O
scanned	O
on	O
a	O
GeneChip	O
®	O
Scanner	O
3000	O
7G	O
.	O

Image	O
signal	O
data	O
,	O
detection	O
calls	O
and	O
annotations	O
were	O
generated	O
for	O
every	O
gene	O
using	O
the	O
Affymetrix	O
Statistical	O
Algorithm	O
MAS	O
5	O
.	O
0	O
(	O
GeneChip	O
®	O
Operating	O
Software	O
v1	O
.	O
3	O
).	O

A	O
log2	O
transformation	O
was	O
conducted	O
and	O
a	O
Student	O
’	O
s	O
t	O
-	O
test	O
was	O
performed	O
for	O
comparison	O
of	O
the	O
two	O
groups	O
(	O
control	O
and	O
heat	O
-	O
shocked	O
).	O

We	O
conducted	O
multiple	O
testing	O
correction	O
—	O
Benjamini	O
and	O
Hochberg	O
—	O
to	O
determine	O
the	O
false	O
discovery	O
rate	O
,	O
and	O
statistical	O
significant	O
genes	O
were	O
identified	O
using	O
Bonferroni	O
correction	O
procedures	O
(−	O
log10	O
pcutoff	O
>	O
6	O
.	O
04	O
)	O
[	O
21	O
].	O

For	O
interpretation	O
of	O
the	O
results	O
,	O
the	O
Ingenuity	O
Pathways	O
Analysis	O
tool	O
(	O
IPA	O
version	O
8	O
.	O
7	O
,	O
Ingenuity	O
®	O
Systems	O
Inc	O
.,	O
Redwood	O
City	O
,	O
CA	O
,	O
USA	O
;	O
[	O
22	O
])	O
was	O
used	O
.	O

IPA	O
is	O
a	O
web	O
-	O
based	O
software	O
application	O
,	O
which	O
enables	O
filtering	O
and	O
dataset	O
comparisons	O
,	O
to	O
identify	O
biological	O
mechanisms	O
,	O
pathways	O
and	O
functions	O
most	O
relevant	O
to	O
experimental	O
datasets	O
or	O
differentially	O
expressed	O
genes	O
.	O

The	O
cut	O
-	O
off	O
criteria	O
for	O
our	O
IPA	O
analysis	O
were	O
:	O
an	O
absolute	O
value	O
of	O
log2	O
ratio	O
≥	O
1	O
.	O
5	O
and	O
a	O
p	O
-	O
value	O
≤	O
0	O
.	O
05	O
.	O

Other	O
web	O
-	O
based	O
resources	O
,	O
such	O
as	O
the	O
GeneCards	O
Human	B-OG
Gene	O
Database	O
[	O
23	O
],	O
The	O
HUGO	O
Gene	O
Nomenclature	O
Committee	O
(	O
HGNC	O
,	O
[	O
24	O
])	O
and	O
the	O
Gene	O
Ontology	O
[	O
25	O
]	O
were	O
also	O
used	O
to	O
further	O
supplement	O
the	O
analysis	O
.	O

The	O
targets	O
identified	O
in	O
the	O
microarray	O
study	O
were	O
validated	O
using	O
qRT	O
-	O
PCR	O
.	O

Runs	O
were	O
performed	O
using	O
TaqMan	O
®	O
RNA	O
-	O
to	O
-	O
CT	O
™	O
1	O
-	O
Step	O
Kits	O
and	O
TaqMan	O
®	O
Assays	O
for	O
:	O
HSPA6	B-GP
and	O
GAPDH	B-GP
(	O
Applied	O
Biosystems	O
).	O

Calibrator	O
RNA	O
was	O
used	O
as	O
the	O
control	O
(	O
Cell	O
Applications	O
Inc	O
.).	O

All	O
assays	O
were	O
performed	O
by	O
Asuragen	O
Services	O
.	O

4	O
.	O

Conclusions	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
temporal	O
gene	O
expression	O
kinetics	O
for	O
HEK	O
cells	O
exposed	O
to	O
hyperthermic	O
stress	O
.	O

Collectively	O
,	O
our	O
results	O
demonstrate	O
that	O
hyperthermic	O
stress	O
triggers	O
a	O
rapid	O
,	O
robust	O
and	O
extensive	O
transcriptional	O
response	O
in	O
HEK	O
cells	O
.	O

The	O
temporal	O
kinetics	O
expression	O
data	O
show	O
that	O
this	O
cellular	O
response	O
is	O
immediately	O
activated	O
in	O
response	O
to	O
stress	O
and	O
is	O
sustained	O
for	O
many	O
hours	O
after	O
exposure	O
.	O

Specifically	O
,	O
we	O
show	O
that	O
the	O
number	O
of	O
upregulated	O
genes	O
increased	O
in	O
logarithmic	O
fashion	O
as	O
a	O
function	O
of	O
time	O
,	O
ranging	O
from	O
466	O
at	O
0	O
h	O
,	O
872	O
at	O
4	O
h	O
and	O
up	O
to	O
1	O
,	O
127	O
at	O
24	O
h	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
previous	O
in	O
vivo	O
studies	O
,	O
which	O
show	O
that	O
HSP70	B-GP
expression	O
is	O
bi	O
-	O
phasic	O
and	O
peaks	O
at	O
both	O
12	O
h	O
and	O
24	O
h	O
post	O
-	O
exposure	O
[	O
5	O
,	O
7	O
,	O
8	O
].	O

However	O
,	O
this	O
data	O
is	O
in	O
contrast	O
to	O
previous	O
in	O
vitro	O
reports	O
,	O
which	O
show	O
that	O
the	O
number	O
of	O
regulated	O
genes	O
is	O
maximal	O
roughly	O
4	O
to	O
12	O
h	O
post	O
-	O
exposure	O
[	O
3	O
,	O
4	O
,	O
5	O
].	O

Furthermore	O
,	O
in	O
this	O
study	O
,	O
we	O
show	O
that	O
many	O
of	O
the	O
genes	O
activated	O
at	O
24	O
h	O
encode	O
for	O
chemokines	B-GP
that	O
play	O
central	O
roles	O
in	O
inflammation	O
(	O
i	O
.	O
e	O
.,	O
IL	B-GP
-	I-GP
8	I-GP
,	O
IL	B-GP
-	I-GP
10	I-GP
,	O
IL	B-GP
-	I-GP
22	I-GP
,	O
IL	B-GP
-	I-GP
15	I-GP
and	O
JAK	B-GP
family	O
kinases	B-GP
).	O

This	O
suggests	O
that	O
the	O
second	O
expression	O
peak	O
at	O
24	O
h	O
is	O
likely	O
due	O
to	O
cellular	O
inflammation	O
.	O

We	O
identified	O
a	O
large	O
group	O
of	O
diverse	O
heat	B-GP
-	I-GP
inducible	I-GP
genes	I-GP
in	O
this	O
work	O
.	O

The	O
temporal	O
kinetics	O
data	O
shows	O
that	O
each	O
individual	O
gene	O
exhibits	O
distinct	O
expression	O
profiles	O
,	O
which	O
vary	O
dramatically	O
in	O
magnitude	O
,	O
onset	O
time	O
and	O
duration	O
of	O
expression	O
.	O

From	O
the	O
data	O
,	O
we	O
determined	O
that	O
the	O
heat	B-GP
-	I-GP
inducible	I-GP
genes	I-GP
can	O
be	O
grouped	O
according	O
to	O
their	O
temporal	O
expression	O
phases	O
.	O

The	O
first	O
group	O
belongs	O
to	O
an	O
immediate	O
-	O
expression	O
phase	O
consisting	O
of	O
genes	O
that	O
are	O
rapidly	O
expressed	O
shortly	O
(	O
i	O
.	O
e	O
.,	O
5	O
–	O
20	O
min	O
)	O
after	O
exposure	O
to	O
hyperthermic	O
stress	O
.	O

The	O
second	O
group	O
consists	O
of	O
genes	O
expressed	O
several	O
minutes	O
up	O
to	O
4	O
h	O
post	O
exposure	O
,	O
and	O
the	O
third	O
group	O
can	O
be	O
considered	O
an	O
“	O
adaption	O
or	O
recovery	O
phase	O
”	O
that	O
occurs	O
4	O
h	O
to	O
24	O
h	O
post	O
exposure	O
.	O

The	O
majority	O
of	O
genes	O
expressed	O
during	O
the	O
immediate	O
expression	O
phase	O
encode	O
for	O
proteins	O
involved	O
in	O
molecular	O
transport	O
,	O
cellular	O
growth	O
and	O
heat	O
shock	O
response	O
.	O

One	O
notable	O
molecular	O
transport	O
gene	O
is	O
HBA1	B-GP
/	O
HBA2	B-GP
,	O
which	O
functions	O
to	O
facilitate	O
the	O
delivery	O
of	O
oxygen	O
.	O

Another	O
interesting	O
finding	O
is	O
that	O
only	O
the	O
well	O
characterized	O
HSPs	B-GP
(	O
i	O
.	O
e	O
.,	O
HSP40	B-GP
and	O
HSP70	B-GP
)	O
are	O
expressed	O
at	O
the	O
early	O
time	O
points	O
,	O
while	O
the	O
smaller	O
HSPs	B-GP
and	O
chaperonins	B-GP
(	O
HSPE1	B-GP
,	O
HSP60	B-GP
;	O
HSPE1	B-GP
,	O
HSP10	B-GP
;	O
HSPB2	B-GP
,	O
HSP27	B-GP
)	O
are	O
expressed	O
at	O
roughly	O
24	O
h	O
post	O
-	O
exposure	O
.	O

Furthermore	O
,	O
other	O
HSPs	B-GP
,	O
such	O
as	O
HSPH1	B-GP
(	O
HSP105	B-GP
),	O
which	O
function	O
primarily	O
to	O
prevent	O
protein	O
aggregation	O
,	O
exhibit	O
maximal	O
expression	O
at	O
the	O
4	O
h	O
time	O
-	O
point	O
.	O

This	O
data	O
strongly	O
supports	O
that	O
each	O
particular	O
type	O
of	O
HSP	B-GP
exhibits	O
expression	O
kinetics	O
that	O
appear	O
to	O
be	O
directly	O
correlated	O
with	O
the	O
function	O
that	O
is	O
required	O
at	O
each	O
time	O
point	O
.	O

In	O
summary	O
,	O
these	O
data	O
provide	O
valuable	O
new	O
insights	O
that	O
give	O
us	O
a	O
much	O
clearer	O
picture	O
of	O
the	O
genes	O
and	O
intracellular	O
signaling	O
pathways	O
that	O
are	O
triggered	O
in	O
human	B-OG
epithelial	O
keratinocytes	O
exposed	O
to	O
hyperthermic	O
stress	O
.	O

Supplementary	O
Table	O
(	O
PDF	O
,	O
2889	O
KB	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

